Join to View Full Profile
1230 York AveThe Rockefeller UniversityNew York, NY 10065
Phone+1 212-327-8067
Fax+1 212-327-8370
Dr. Nussenzweig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1986 - 1987- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1986 - 1986
- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1982 - 1985
New York University School of MedicineClass of 1982
Certifications & Licensure
NY State Medical License 1990 - 2026
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member National Academy of Sciences, 2010
- Elected Member American Academy of Arts and Sciences, 2006
- Elected Member Institute of Medicine, 2009
- Join now to see all
Publications & Presentations
PubMed
- Regulated somatic hypermutation enhances antibody affinity maturation.Julia Merkenschlager, Andrew G T Pyo, Gabriela S Silva Santos, Dennis Schaefer-Babajew, Melissa Cipolla
Nature. 2025-03-19 - Bispecific antibodies targeting the N-terminal and receptor binding domains potently neutralize SARS-CoV-2 variants of concern.Adonis A Rubio, Viren A Baharani, Bernadeta Dadonaite, Megan Parada, Morgan E Abernathy
Science Translational Medicine. 2025-03-05 - 1 citationsAffinity maturation of antibody responses is mediated by differential plasma cell proliferation.Andrew J MacLean, Lachlan P Deimel, Pengcheng Zhou, Mohamed A ElTanbouly, Julia Merkenschlager
Science. 2025-01-24
Journal Articles
- Relationship Between Intact HIV-1 Proviruses in Circulating CD4+ T Cells and Rebound Viruses Emerging During Treatment InterruptionMichel C Nussenzweig, Thiago Y Oliveira, Marina Caskey, Proceedings of the National Academy of Sciences
- Article the Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch RecombinationThiago Y Oliveira, Michel C Nussenzweig, ScienceDirect
- Combination Therapy with Anti-HIV-1 Antibodies Maintains Viral SuppressionMichael S Seaman, Katrina Millard, Marina Caskey, Michel C Nussenzweig, Roy M Gulick, Thiago Y Oliveira, Nature
- Join now to see all
Press Mentions
Immune Cell Mechanism Improves Antibody ProductionMarch 20th, 2025- How Broadly Neutralizing Antibodies Are Driving Next-Gen VaccinesJanuary 23rd, 2025
- Broadly Neutralizing Antibodies: The Key to Next-Generation Vaccine BreakthroughsJanuary 23rd, 2025
- Join now to see all
Grant Support
- Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 AntibodiesCALIFORNIA INSTITUTE OF TECHNOLOGY2013–2028
- Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 AntibodiesCALIFORNIA INSTITUTE OF TECHNOLOGY2013–2028
- Broad neutralization of pandemic threat coronavirusesROCKEFELLER UNIVERSITY2022–2024
- Broad neutralization of pandemic threat coronavirusesROCKEFELLER UNIVERSITY2022–2024
- Broad neutralization of pandemic threat coronavirusesROCKEFELLER UNIVERSITY2022–2024
- Broad neutralization of pandemic threat coronavirusesROCKEFELLER UNIVERSITY2022–2024
- Immunity And Infectious DiseaseNational Institute Of Allergy And Infectious Diseases2008–2012
- Cellular Dynamics In Germinal Centers During VaccinationNational Institute Of Allergy And Infectious Diseases2007–2012
- On The Role Of 53BP1 In Protecting DNA ENDS During RepairNational Center For Research Resources2011
- Identification Of HIV Reactive AntibodiesNational Center For Research Resources2010–2011
- Protein Expression CoreNational Institute Of Allergy And Infectious Diseases2009–2011
- Novel Approaches For Vaccine DesignNational Institute Of Allergy And Infectious Diseases2009–2011
- FACS CoreNational Institute Of Allergy And Infectious Diseases2009–2011
- Class Switch Recombination In B LymphocytesNational Institute Of Allergy And Infectious Diseases2009–2011
- Broadly Neutralizing To HIVNational Institute Of Allergy And Infectious Diseases2009–2011
- AdministrativeNational Institute Of Allergy And Infectious Diseases2009–2011
- Activation Induced Deaminase (AID) Interacting ProteinsNational Center For Research Resources2008–2011
- Targeting Dendritic Cells For Immune ToleranceNational Institute Of Allergy And Infectious Diseases2007–2011
- Protein ExpressionNational Institute Of Allergy And Infectious Diseases2007–2011
- Human Antibody Tolerance In Normal And SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2010
- Regulators Of Receptor Editing In Developing B CellsNational Institute Of Allergy And Infectious Diseases2004–2008
- "Activation Induced Deaminase" (AID) Interacting ProteinsNational Center For Research Resources2004–2007
- Signaling Pathways In AutoimmunityNational Institute Of Allergy And Infectious Diseases1999–2003
- Antigen Targeting To Dendritic CellNational Institute Of Allergy And Infectious Diseases2002
- Signal Transduction By IGM In B LymphocytesNational Institute Of Allergy And Infectious Diseases1998–2002
- V(D)J Gene Rearrangement In Peripheral B CellsNational Center For Research Resources1999
- DEC-205 And AutoimmunityNational Institute Of Allergy And Infectious Diseases1996–1999
- Signalling Pathways In AutoimmunityNational Institute Of Allergy And Infectious Diseases1994–1998
- Signal Transduction By IGM In B LymphocytesNational Institute Of Allergy And Infectious Diseases1993–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
